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Background-—We examined whether type of menopause affects sex differences in coronary heart disease (CHD) events and
whether the impact is similar in blacks and whites.
Methods and Results-—Participants were enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS)
cohort between 2003 and 2007 without CHD at baseline (n=23 086). Cox regression models were used to calculate the hazard of
incident nonfatal CHD (definite or probable myocardial infarction) and acute CHD death, adjusting for age, age at last menstrual
period <45 years, region, education level, income, diabetes, smoking, systolic blood pressure, lipid levels, albumin-creatinine ratio,
physical activity, C-reactive protein, body mass index, waist circumference, and medication use. White women in natural
menopause (hazard ratio [HR], 0.45; 95% confidence interval [CI], 0.31, 0.66) and surgical menopause (HR, 0.65; 95% CI, 0.42,
0.99) had a reduced hazard of nonfatal events, compared to white men. Black women in natural menopause (HR, 0.69; 95% CI,
0.47, 1.03), but not surgical menopause (HR, 0.81; 95% CI, 0.51, 1.29), had a marginally reduced hazard of nonfatal events,
compared to black men. Women had lower risk of acute CHD death than men regardless of their menopause type and race.
Conclusions-—Sex differences in the risk of incident CHD events were larger among whites than blacks and varied by type of
menopause. Women consistently had a lower risk of incident CHD death than men, but the magnitude of sex differences was
greater in whites than blacks for nonfatal events, regardless of menopause type. ( J Am Heart Assoc. 2015;4:e001881 doi:
10.1161/JAHA.115.001881)
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W omen have a lower risk of incident coronary heartdisease (CHD) events, compared to men, although sex
differences narrow in mid-life.1,2 As a mid-life milestone,
menopause is commonly held as a risk factor for CHD,2 and
the National Cholesterol Education Panel stated that women’s
CHD risk is clinically significant after they enter menopause.3
Controversy exists as to whether menopause narrows sex
differences in incidence of CHD events and how it might do so.
Alternate explanations include decelerating rates of CHD in
mid-life men or increased CHD risk factor burden in aging
women.2,4,5 The mechanism through which menopause might
act is not known, but may differ by menopause type. Several
studies suggest that natural menopause does not increase risk
of cardiovascular (CV) events (CVEs),6 but bilateral oophorec-
tomy (BSO)7,8 and hysterectomy (with or without BSO)8–10
increase CHD events, compared to natural menopause.
Sudden declines in estrogen levels with BSO have been cited,7
as well as poorer CHD risk factor profiles of women who
undergo these procedures.8,11,12 However, natural menopause
at <45 years of age is associated with increased CHD risk.13,14
Though explanations are speculative and include chronic
disease or autoimmune disorders, this age cutpoint may
identify a unique population at particular risk.
Approximately 600 000 hysterectomies are performed
annually in the United States.15 Approximately half include
concomitant BSO, although this proportion is declining.15
These procedures are more common in the southern United
States.15,16 and may be more common in African Ameri-
cans,15 although 1 recent study found no difference between
blacks and whites.16 Reports from other cohorts note that sex
differences in subclinical CHD are more pronounced in whites
than in blacks, suggesting that sex differences should be
similar by race after consideration of menopause type.17
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ORIGINAL RESEARCH
Available literature on menopause type and CHD risk has not
presented data for African Americans or examined whether
risk estimates differ between nonfatal CHD and CHD death.
Reports have not examined the risk of CHD in types of
menopause, compared to risks in men; this would estimate
the magnitude of CHD sex differences with different types of
menopause and reduce confounding by age introduced by
comparison of pre- and postmenopausal women.
Women and their physicians may consider CHD risk when
considering whether to undergo elective hysterectomy and/or
BSO.8 Although CHD risk factors may not differ by menopause
type or change with gynecological surgery,18 at least 1
medical group advocates closer monitoring of blood pressure
and lipids after the menopausal transition.19 Therefore, it is
important to investigate the impact of menopause type upon
sex differences in CHD risk. We used data from the Reasons
for Geographic and Racial Differences in Stroke (REGARDS)
study, a large biracial cohort, to examine whether type of
menopause differently increases risk of CHD events in
women, compared to men, whether any associations persist
after adjustment for CHD risk factors and region, whether
associations differ between nonfatal MI and acute CHD death,
and whether any of these relationships differ by race. We
hypothesized that sex differences would be more pronounced
for women who had undergone BSO than other menopause
types and that these differences by menopause type would be
similar in blacks and whites.
Methods
REGARDS is a prospective cohort study designed to examine
regional and racial influences on stroke mortality. It over-
sampled blacks and residents of the southeastern stroke belt
region, which includes Alabama, Arkansas, Georgia, Kentucky,
Lousiana, Mississippi, North Carolina, South Carolina, Ten-
nessee, and Virginia; the Carolinas and Georgia have the
highest stroke incidence and are sometimes called the
“stroke buckle.”9 Briefly, 30 239 participants at least
45 years of age were recruited from a commercially available
list of residents using a combination of postal mailings and
telephone and enrolled between January 2003 and October
2007. Using a computer-assisted telephone interview (CATI),
trained interviewers obtained demographic information and
medical history, and an in-home brief physical examination
was conducted 3 to 4 weeks after the telephone interview.
Participants are followed by CATI every 6 months for
suspected incident CVEs and change in cognitive function.
The study protocol was reviewed and approved by the
participating institutions institutional review boards. All par-
ticipants provided written informed consent.
For this report, we excluded participants with prevalent
CHD at baseline (self-reported history of myocardial infarction
[MI], coronary revascularization procedure, evidence of pre-
vious MI on the baseline electrocardiogram [ECG]) (n=5433),
missing follow-up data (n=489), missing menopause status at
baseline (n=338), and premenopausal women (n=1031);
24 123 participants were included. Events with complete
ascertainment through December 31, 2011 were included in
this analysis. The mean (SD) follow-up time was 5.7 (2.0)
years.
Acute CHD Events
Suspected CHD events were adjudicated by a team of experts
following published guidelines.20 For MI, medical records were
examined for the presence of signs or symptoms suggestive
of ischemia; a rising and/or falling pattern in cardiac troponin
level or creatine phosphokinase–myocardial band level over 6
or more hours with a peak level greater than twice the upper
limit of normal (diagnostic cardiac enzymes); and ECG
changes consistent with ischemia or MI, guided by the
Minnesota code and classified as evolving diagnostic, positive,
nonspecific, or not consistent with ischemia.21 Definite MIs
were those with diagnostic enzymes or ECG. Probable MIs
were those with elevated, but not diagnostic (ie, equivocal),
enzymes with a positive, but not diagnostic, ECG; or, if
enzymes were missing, with a positive ECG in the presence of
ischemic signs or symptoms. Only definite or probable MIs
were included in this study. For acute CHD death, the medical
history, hospital records, autopsy reports, interviews with next
of kin or proxies, and death certificate or National Death Index
data were reviewed to adjudicate the cause of death, with
definite or probable CHD death included in this analysis.
Cases were assigned to 2 adjudicators and disagreements
were adjudicated by committee, with a j>0.80 for the
presence of definite or probable MI or definite or probable
acute CHD death. Primary outcomes were total CHD events,
consisting of definite or probable CHD deaths and nonfatal
definite or probable MIs, as well as acute CHD death and
nonfatal MI separately.
Type of Menopause
At baseline, women were asked, “Have you gone through the
change of life?” and “How old were you at the time of your last
menstrual period?” To identify those with surgical menopause,
participants were asked, “Have you ever had an ovary
removed?” If they answered “yes,” participants were asked,
“How many ovaries were removed?” Women were also asked,
“Have you ever had a hysterectomy, that is, surgery to remove
your uterus or womb?” Women were classified as having
menopause resulting from BSO, with or without hysterectomy;
menopause resulting from hysterectomy alone; or natural
menopause. Women were further categorized as being in
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natural or surgical menopause. Women with menopause
resulting from BSO with or without hysterectomy were defined
as such owing to the fact that the ovaries continue to make
androgens in postmenopause, even as estrogen production
ceases,22 and androgens have been postulated to be influen-
tial in atherosclerotic disease in women.23 Natural meno-
pause was defined as a last menstrual period occurring
≥12 months before the interview, in the absence of hyster-
ectomy or BSO. If women had stopped menstruating before
hysterectomy or BSO, they were defined as being in natural
menopause.
Covariates
Age, sex, race, income, education, and smoking status were
self-reported. Annual household income was dichotomized at
$35 000 based on previous analyses in this cohort,24 and
education was dichotomized at high school diploma. Smokers
were defined as having smoked at least 100 cigarettes in their
lifetime and smoking now, even occasionally. Participants
were asked, “How many times per week do you engage in
intense physical activity, enough to work up a sweat?” Data
on antihypertensive drugs and statin use were based on self-
report and in-home pill bottle review, respectively, and data on
estrogen therapy were based on in-home reviews conducted
by trained interviewers. Anthropometrics and blood pressure
were ascertained during an in-home visit using a standardized
protocol; body mass index (BMI) and waist circumference
have previously been demonstrated to predict mortality risk
independently in REGARDS.25 Fasting blood and urine mark-
ers included total cholesterol, high-density lipoprotein (HDL)
cholesterol, glucose, high-sensitivity C-reactive protein (CRP),
serum creatinine, and urinary albumin and creatinine from a
spot urine specimen.26 CRP was log-transformed and mod-
eled as a continuous variable. Diabetes was classified as
present if the fasting glucose level was 126 mg/dL or higher
(nonfasting glucose, ≥200 mg/dL) or if the participant was
taking diabetes medications (to convert glucose to millimoles
per liter, multiply by 0.0555). Urinary albumin and creatinine
were used to define the urinary albumin-creatinine ratio (ACR).
Statistical Analysis
Primary analyses were stratified by race/ethnicity. Baseline
participant characteristics were tabulated by the categories of
natural menopause, BSO with or without hysterectomy,
hysterectomy alone, and men, using chi-square and ANOVA
tests. Cox proportional hazards regression modeling was used
to examine the association between menopause type and
incident CHD with men as a reference for each menopause
type. A parallel set of models was generated that categorized
women as being in natural or surgical menopause. Models
were adjusted incrementally for age, region (Model 1), and
further for education and income (Model 2); model 2
covariates and total cholesterol, HDL, triglycerides, smoking,
exercise, systolic blood pressure, diabetes, ACR, use of
antihypertensive medications and statins, and CRP (Model 3);
model 3 covariates and estrogen therapy at baseline (Model
4); model 4 covariates and waist circumference and BMI
(Model 5); and model 5 covariates and menopause age
dichotomized at 45 years (Model 6). Missing data in covari-
ates were imputed using chained equations with 20 data sets,
in STATA 12 (StataCorp LP, College Station, TX).27
To determine whether the relationship between menopause
type and CHD incidence differed significantly by race, Cox
models were created that pooled whites and blacks and
menopause types and included an interaction term between
race and menopause category in the fully adjusted model.
Race-stratified models were also created that evaluated an
interaction term between age at last menstrual period and type
of menopause to determine whether the association between
menopause type and incident CHD differed in women who
were <45 years versus ≥45 years of age. The assumptions of
proportionality were met. Individuals were censored at the
time of their event, death, or the end of follow-up. Statistical
significance for all analyses was considered as P<0.05 and for
interactions as P<0.10. Analyses were conducted using SAS
(9.3; SAS Institute Inc., Cary, NC) and STATA 12.
Results
Sample Characteristics
Table 1 lists the baseline characteristics by menopausal
status in blacks (n=9669) and whites (n=13 417). Among
blacks, men were similar in age and education level to women,
but men reported higher income. Black men were more likely
to smoke, exercise, and had lower BMI than black women, but
blood pressure and HDL were poorer. Among whites, similar
patterns were observed, except that smoking prevalence and
BMI were similar by sex groups.
Among blacks, women who had undergone natural men-
opause were of similar age, education, and income, compared
to women in surgical menopause, although the proportion of
women with menopause at <45 years of age was lower
among women in natural menopause. Surgical menopause
was only slightly more common among women living in the
stroke belt or buckle than those residing elsewhere. Behaviors
such as smoking and exercise were similar across menopause
categories, as were metabolic profiles. Black women in
natural menopause were less likely to use blood pressure
medications and estrogen therapy, compared to black women
in surgical menopause. Among whites, similar patterns were
observed, except that white women in natural menopause had
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higher income than white women in surgical menopause.
Surgical menopause was more common among white women
living in the stroke belt or buckle. Regional differences in
menopause type were more pronounced among whites than
among blacks.
Total CHD Events
Events by nonfatal versus fatal status, sex, menopause type,
and race are shown in Table 2. Table 3 shows the risk of total
CHD, fatal CHD, and nonfatal CHD by menopause type,
stratified by race. Black women had a significantly lower
hazard of any CHD event, compared to black men, regardless
of menopause type, and white women also had a significantly
lower hazard of any CHD event, compared to white men,
regardless of menopause type. In the fully adjusted model
combining blacks and whites with total CHD events as the
outcome, the race by menopause category interaction term
had a P=0.09. This interaction was owing to differences in
association between menopause category and nonfatal CHD
events by race.
Fatal CHD Events
In minimally- and fully adjusted models, black and white women
had a markedly lower hazard of fatal CHD events than men,
regardless of menopause type (Table 3).These associations
did not differ by race (P interaction of menopause cate-
gory 9 race = 0.89). Figure 1 illustrates how the point esti-
mates and 95% confidence intervals (CIs) for the hazard ratios
differed with adjustment for each set of covariates. Whereas
95% CIs overlapped, adjustment for age at menopause
<45 years decreased the point estimates, particularly in white
women who had undergone hysterectomy (P=0.04 for interac-
tion for menopause type and age at menopause <45 years).
Nonfatal CHD Events
When we examined risk for nonfatal CHD events, a different
pattern emerged. Among blacks, women in natural meno-
pause had a slightly lower hazard for nonfatal events than
men, although these results did not reach statistical signif-
icance (Table 3). Women in any type of surgical menopause
had a statistically similar hazard for nonfatal CHD events.
Among whites, women in natural menopause had lower risk
than men after adjustment for other covariates (Figure 2).
White women in surgical menopause also had a decreased
hazard for nonfatal events, compared to men, although the
CIs for subcategories of surgical menopause were wider
(Table 3). This difference in patterns between blacks and
whites was statistically significant (P=0.03 for interaction
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models). For white women, in models stratified by age at
menopause <45 years, similar patterns as the nonstratified
analysis were noted (results not shown).
Discussion
In the REGARDS study, in both blacks and whites, women had
a lower risk of total CHD events than men, regardless of
menopause category. This reduced risk persisted after
adjustment for an extensive list of potential confounders.
Compared to black men, black women had approximately half
the hazard of any CHD event, compared to men. Compared to
white men, white women also had a significantly reduced
hazard of CHD. These sex differences were even more
pronounced for risk of acute fatal CHD events in both blacks
and whites. However, sex differences were less pronounced
for nonfatal CHD events. Patterns varied by race, with no
significant sex differences observed in nonfatal CHD risk
Table 2. Incident CHD Events Through December 2011



























Person-years of follow-up 21 001 18 684 7732 6326 38 489 23 620 7859 8541
Total CHD events 192 111 42 37 351 83 39 37
Fatal CHD events 91 47 13 12 99 27 11 8
Nonfatal CHD events 101 64 29 25 252 56 28 29
CHD indicates coronary heart disease.
Table 3. Total, Fatal, and Nonfatal Acute CHD Events in Cox Regression Models, Hazard Ratios, and 95% Confidence Intervals




























0.63 (0.50 to 0.80) 0.58 (0.41 to 0.80) 0.64 (0.45 to 0.91) 0.39 (0.30 to 0.49) 0.51 (0.36 to 0.71) 0.45 (0.32 to 0.63)
Fully adjusted* 0.58 (0.43 to 0.78) 0.55 (0.35 to 0.83) 0.61 (0.38 to 0.94) 0.40 (0.29 to 0.55) 0.44 (0.28 to 0.70) 0.46 (0.30 to 0.72)




0.57 (0.40 to 0.81) 0.38 (0.21 to 0.68) 0.45 (0.24 to 0.82) 0.46 (0.30 to 0.70) 0.50 (0.27 to 0.94) 0.35 (0.17 to 0.72)
Fully adjusted* 0.45 (0.28 to 0.71) 0.31 (0.15 to 0.63) 0.37 (0.18 to 0.76) 0.28 (0.15 to 0.52) 0.20 (0.08 to 0.49) 0.17 (0.06 to 0.42)




0.69 (0.50 to 0.94) 0.75 (0.50 to 1.14) 0.81 (0.53 to 1.26) 0.36 (0.27 to 0.48) 0.51 (0.34 to 0.75) 0.49 (0.33 to 0.72)
Fully adjusted* 0.69 (0.47 to 1.03) 0.79 (0.46 to 1.33) 0.84 (0.49 to 1.45) 0.45 (0.31 to 0.66) 0.62 (0.36 to 1.04) 0.67 (0.41 to 1.10)
0.81 (0.51 to 1.29) 0.65 (0.42 to 0.99)
Reference group is men. CHD indicates coronary heart disease.
*Adjusted for age, age at menopause <45 years (yes/no), less than high school education, annual income ≤$35 000; body mass index, waist circumference, level of total cholesterol, high-
density lipoprotein cholesterol, systolic blood pressure, albumin-creatinine ratio, and C-reactive protein; current smoking (yes/no), diabetes (yes/no), never exercise (yes/no), use of
antihypertensive (yes/no), statins (yes/no), estrogen therapy (yes/no).
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among blacks. White women in natural menopause and
surgical menopause continued to have lower nonfatal CHD
risk than men. Thus, frequency of surgical menopause was
not responsible for the lack of sex differences in nonfatal CHD
in blacks as opposed to whites.
Our results confirm that the risk of having any incident
CHD event in women is lower than in men.2 We also note that
this low risk persists despite the postmenopausal state,
regardless of menopause type, and despite comprehensive
adjustment for traditional and unconventional CHD risk
factors, including renal function, CRP, and medication use.
This suggests that other factors besides menopause status
and CHD risk factors are driving sex differences in mid-life.
Previous investigators noted that although the risk of incident
CHD increases rapidly in women after 50 years of age, the
approximate age of menopause, evaluation of risk for CHD
changes on a log-scale reveal a gradual increase in risk rather
than a sharp change in risk (as is observed for breast
cancer).2,5 Therefore, men may have a slower rate of increase
in CHD events in mid-life, whereas women’s rate of increase
remains constant.2,5 In other words, the greater sex differ-
ences observed at younger ages, as opposed to older ages,
may be owing to changing risk in men rather than women, as
well as the difficulty in demonstrating greater relative
differences in events as the number of events increases.
To our knowledge, other reports have not examined the
impact of menopause type upon sex differences in CHD risk.
Previous literature has conflicted regarding the degree of CHD
risk conferred by different types of menopause. In the
Women’s Health Initiative Observational Study, the risk of any
CVE associated with menopause type was examined, using
natural menopause as a referent group; CV disease was
defined as MI, stroke, coronary revascularization, or CHD
death. Women who had undergone hysterectomy had a
poorer CHD risk profile than women in natural menopause,
regardless of oophorectomy status, and the increased risk
Figure 1. Risk of acute fatal CHD events by menopause category (hazard ratios and 95% confidence
intervals), with men as referent group. Black participants are shown in the top panel and white
participants shown in the bottom panel. Model 1 adjusts for age and region. Model 2 adjusts for less
than high school education and annual income <$35 000. Model 3 adjusts for level of total cholesterol,
high-density lipoprotein cholesterol, systolic blood pressure, albumin-creatinine ratio, and C-reactive
protein; current smoking (yes/no), diabetes (yes/no), never exercise (yes/no), use of antihypertensives
(yes/no), and statins (yes/no). Model 4 further adjusts for estrogen therapy. Model 5 further adjusts for
waist circumference (cm) and body mass index (kg/m2). Model 6 further adjusts for age at last
menstrual period <45 years (yes/no). BSO indicates bilateral oophorectomy; CHD, coronary heart
disease; CI, confidence interval.
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associated with hysterectomy was diminished after adjust-
ment for CHD risk factors.28 In the Nurses’ Health Study, BSO
was associated with increased CHD risk, compared to natural
menopause, after adjustment for age and smoking.7 A more
recent analysis suggested that BSO was associated with
greater CHD risk, compared to hysterectomy alone, after
adjustment for a more extensive list of covariates than age
and smoking.8 Our results are similar to these findings, in that
we found that, of all the menopause categories, black and
white women in natural menopause had the lowest risk of
nonfatal CHD events, compared to men.
Our report differs from previous studies that suggested
women in surgical menopause might lose their advantage,
compared to men, even as men were not examined along with
subtype of menopause. Analyses in other cohorts have
reported that women who undergo surgical menopause tend
to have poorer CHD risk factor profiles29 than other women,
particularly among blacks.30 One exception reported that
annual changes in CHD risk factors did not vary by
menopausal type.18 We found that surgical menopause was
not associated with a greater risk of fatal CHD events. Though
the sudden cardiac death that comprises a subset of fatal
CHD is more common in men than women, myocardial
ischemia is believed to be the primary etiology.31 However,
other reports have noted that testosterone levels are inversely
associated with QT intervals in men, but not women,32 and it
is possible that the higher androgen levels observed in men
confer a relative disadvantage regarding arrhythmias. The risk
of acute CHD events has also declined with time, a finding
attributed to more-intensive CHD risk factor management
with lifestyle modification and pharmacotherapy.33 It is
possible that these secular trends may have contributed to
the decrease in CHD risk associated with surgical menopause.
We also found that the black women who underwent
surgical menopause and natural menopause in REGARDS had
a similar risk of nonfatal CHD events, compared to black men,
regardless of menopause type. White women, particularly
white women who underwent natural menopause, had a lower
Figure 2. Risk of acute nonfatal CHD events by menopause category (hazard ratios and 95%
confidence intervals), with men as referent group. Black participants are show in the top panel and
white participants shown in the bottom panel. Model 1 adjusts for age and region. Model 2 adjusts for
less than high school education and annual income <$35 000. Model 3 adjusts for level of total
cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, albumin-creatinine ratio, and
C-reactive protein; current smoking (yes/no), diabetes (yes/no), never exercise (yes/no), use of
antihypertensives (yes/no), and statins (yes/no). Model 4 further adjusts for estrogen therapy. Model
5 further adjusts for waist circumference (cm) and body mass index (kg/m2). Model 6 further adjusts
for age at last menstrual period <45 years (yes/no). BSO indicates bilateral oophorectomy; CHD,
coronary heart disease; CI, confidence interval.
DOI: 10.1161/JAHA.115.001881 Journal of the American Heart Association 8















risk of nonfatal CHD events, compared to white men. It is
possible that the androgen production that distinguishes
menopause types22 is influential in the pathophysiology of the
diffuse atherosclerosis that characterizes nonfatal events, and
racial/ethnic differences by androgen level exist. Previous
studies have conflicted as to whether black and white women
have different levels of androgens,34–37 so it is unknown
whether differences in androgen profile might explain risk in
whites, but not blacks. Persistence of these patterns after
adjustment for an extensive list of CHD risk factors suggests
that a higher risk-factor burden in blacks does not contribute.
Younger age at menopause was associated with increased
hazard of fatal CHD in white women, given that adjustment for
this factor increased women’s advantage, compared to men.
Previous studies have noted consistent relationships with
younger age at menopause in white populations and
increased risk of any CHD event,13,14 particularly fatal CHD.
Smoking increases risk of earlier menopause,14 although the
association persisted after adjustment for smoking. Autoim-
mune disease may also increase risk of early menopause,38
although such conditions are uncommon. It is possible that
the changes in sex steroid profile that characterize the
menopause may be cumulative over time, with younger ages
at menopause leading to increased risk. Adjustment for age at
menopause led to minimal change among blacks, perhaps
related to the reduced sex differences among blacks.
Despite the large numbers of black and white participants,
the number of fatal CHD events was modest, and estimates of
fatal CHD risk should be interpreted with caution. Age at
menopause was self-reported. Women who had undergone
menopause as a result of hysterectomy alone have been
reported to have slight reductions in androgens, but with
smaller reductions compared to women in natural menopause
or with BSO (presumably owing to unintended ovarian
infarction during oophorectomy) and thus were defined as
such.22 Women tend to under-report BSO in the context of
hysterectomy,39 and thus the category of women with
hysterectomy only may have included women with bilateral
oophorectomy as well. Studies have reported high correlation
between ultrasound scans and self-report of hysterectomy,40
whereas the positive predictive value for self-report of
oophorectomy is lower.39 Precise measures of diet and
physical activity were not available. Strengths of this study
include its large sample size and national sampling frame,
allowing adjustment for regional variation in surgeries and
CHD risk, as well as stratified analyses by race. Additional
strengths included adjudication of CHD endpoints as well as
examination of CHD alone instead of a composite endpoint. In
addition, REGARDS measured a comprehensive list of both
classic and nontraditional CHD risk factors that were included
in adjustment. Finally, the examination of race and sex
differences has not previously been examined.
In a national population-based sample of blacks and
whites, we found that menopausal women had a lower risk of
CHD events than men after consideration of an extensive list
of potential confounders. This advantage was particularly
pronounced for fatal CHD events, regardless of menopause
type, in both whites and blacks. Regarding nonfatal CHD
events, white women retained their advantage regardless of
menopause type, whereas black women had a similar risk to
black men for nonfatal CHD events regardless of menopause
type. For black women, our findings are reassuring, in that
CHD risk does not seem to vary significantly by menopause
type, compared to men, and, moreover, that women have
lower risk for fatal CHD, even in postmenopause, compared to
men. For white women, women are still at lower risk than men
for any type of CHD event. Exploration of factors that
contribute nonfatal MI, and, particularly, to the sex advantage
in white women, compared to white men, and the absence of
this advantage in black women and black men, is needed.
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